Cancer Proteomics

From Bench to Bedside

Editors:

ISBN: 978-1-58829-858-4 (Print) 978-1-59745-169-7 (Online)

Table of contents (11 chapters)

  1. Front Matter

    Pages I-XII

  2. Proteomics Technologies

    1. Front Matter

      Pages 1-1

    2. No Access

      Book Chapter

      Pages 3-35

      Current and Emerging Mass Spectrometry Instrumentation and Methods for Proteomic Analyses

  3. Cell Signaling Proteomics

    1. Front Matter

      Pages 37-37

    2. No Access

      Book Chapter

      Pages 39-57

      Integration of Genomics and Proteomics in Dissecting p53 Signaling

    3. No Access

      Book Chapter

      Pages 59-77

      Proteomic Profiling of Tyrosine Kinases as Pharmacological Endpoints for Targeted Cancer Therapy

  4. Tumor Proteomics

    1. Front Matter

      Pages 79-79

    2. No Access

      Book Chapter

      Pages 81-99

      Oncoproteomics for Personalized Management of Cancer

    3. No Access

      Book Chapter

      Pages 101-120

      Application of Serum and Tissue Proteomics to Understand and Detect Solid Tumors

    4. No Access

      Book Chapter

      Pages 121-137

      Insight on Renal Cell Carcinoma Proteome

    5. No Access

      Book Chapter

      Pages 139-159

      Proteomics in Lung Cancer

    6. No Access

      Book Chapter

      Pages 161-187

      Proteomic Strategies of Therapeutic Individualization and Target Discovery in Acute Myeloid Leukemia

    7. No Access

      Book Chapter

      Pages 189-207

      New Tumor Biomarkers

  5. Bioinformatics and Regulatory Aspects of Proteomics

    1. Front Matter

      Pages 209-209

    2. No Access

      Book Chapter

      Pages 211-235

      Annotating the Human Proteome

    3. No Access

      Book Chapter

      Pages 237-258

      Regulatory Issues in the Co-Development of Oncology Drugs and Proteomic Tests: An Overview

  6. Back Matter

    Pages 259-264